Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11685746 Heteroaryl compounds for treating Huntington's disease

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

PTC Therapeutics, Inc.

0

Current Assignee

PTC Therapeutics, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 27, 2023

0

Patent Application Number

172548480

Date Filed

June 25, 2019

0

Patent Citations

US Patent 7910578 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use

0

US Patent 8314119 Azaadamantane derivatives and methods of use

0

US Patent 8563550 Imidazolothiadiazoles for use as protein kinase inhibitors

0

US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes

0

US Patent 9399649 Compounds for treating spinal muscular atrophy

0

US Patent 9371336 Compounds for treating spinal muscular atrophy

0

US Patent 7326711 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents

0

US Patent 7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors

0

...

Patent Primary Examiner

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11685746 Heteroaryl compounds for treating Huntington's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool